NCT06447090
- Conditions
- Relapse Acute Myeloid Leukemia
- Locations
-
- Institute of Hematology & Blood Diseases Hospital, China Tianjin, Tianjin Municipality, China
Clinical trial condition
Relapse Acute Myeloid Leukemia
Explore clinical trials studying Relapse Acute Myeloid Leukemia. Study availability and eligibility vary by location and protocol.
2 public trials
1 recruiting study
Relapse Acute Myeloid Leukemia trial results
Not Yet Recruiting
Aclarubicin Plus With Azacitidine and Venetoclax in the Treatment of Acute Myeloid Leukemia
NCT07486726
- Conditions
- Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
- Locations
-
- Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Shanghai, China
- Shanghai Jing'an District Beizhan Hospital Shanghai, China
- Shanghai Traditional Chinese Medicine Hospital Shanghai, China
- Tongren Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, China